City
Epaper

Plea in SC seeks modification of free corona test order

By IANS | Updated: April 11, 2020 16:15 IST

A doctor moved the Supreme Court on Saturday to seek modification of a court order directing private laboratories to conduct COVID-19 test for free, and sought the test should be free only for EWS persons with immediate reimbursement by the government.

Open in App

New Delhi, April 11 A doctor moved the Supreme Court on Saturday to seek modification of a court order directing private laboratories to conduct COVID-19 test for free, and sought the test should be free only for EWS persons with immediate reimbursement by the government.

Petitioner Dr Kaushal Kant Mishra, a senior orthopaedic surgeon, pleaded through advocate Pooja Dhar that at a time when corona testing across the country has to be ramped up since India has entered the most critical phase, the private labs have been burdened with free tests.

He argued that this has been done by ignoring the fact that the few pathogen labs are well equipped at this hour of crisis.

The plea claimed that the move would actually disincentivize private labs to continue to function.

"The present coronavirus numbers in India are gradually increasing, and are likely to see a severe spike in the coming weeks. This is the point at which testing capacities must be at their maximum so that the governmental efforts to contain its spread can be suitably supplemented," the petitioner contended.

Dr Mishra sought modification of the April 8 order and urged the top court to allow private labs to carry out COVID-19 test as per rates stipulated in the ICMR advisory (Rs 4,500), but allowing free test for below poverty line or EWS categories with immediate reimbursement by the government.

He cited that in the UK, private labs are charging $425 per test or Rs 32,500.

"In addition, it is necessary that all (state) governments start settin up pathogen labs in municipal and panchayat areas so that free tests by the government concerned can be increased," said the plea.

The plea contended that government sources have been quoted as saying that the coming week is a make-or-break week as far as coronavirus testing is concerned, and pointed out that the private labs have far greater mobility and reach because they are making money.

On April 8, a bench comprising Justices Ashok Bhushan and S Ravindra Bhat said: "The tests related to COVID-19, whether in approved government laboratories or approved private laboratories shall be free of cost. The respondents (Union of India) shall issue necessary direction in this regard immediately."

The apex court order came on a petition filed by advocate Shashank Deo Sudhi challenging the Indian Council of Medical Research (ICMR) advisory to fix maximum Rs 4,500 for corona test by private entities.

The petitioner had also sought direction that all such tests be conducted by accredited pathological laboratories, and to strike down the ICMR advisory for allegedly being violative of Articles 14 and 21 of the Constitution.

( With inputs from IANS )

Tags: Shashank deo sudhiindiaNew DelhiIcmrSupreme CourtPooja DharThe new delhi municipal council
Open in App

Related Stories

CricketIND vs PAK 2025 Live Streaming: Head-to-Head Record, When and Where to Watch India vs Pakistan Asia Cup Final

BusinessVodafone Idea Share Price Falls as Supreme Court Postpones AGR Dues Hearing to Oct 6

BusinessVodafone Idea Share Price Falls By 6% Ahead of Supreme Court Hearing On Rs, 9450 Crore AGR Dues

NationalDelhi Metro Tragedy: Woman Falls or Jumps From Supreme Court Station; Investigation Underway

BusinessVodafone Idea Shares Rise by 1%: Telecom Stock Jumps 15% in One Month After Government Signals Support on AGR Dues

स्वास्थ्य Realted Stories

HealthDelhi HC orders Army to grant disability pension to retired nursing officer

HealthOver 11.31 lakh health camps organised under Swasth Nari, Sashakt Nari Abhiyaan: Govt

HealthHigh carb, saturated fat, low protein intake driving diabetes, obesity in India: ICMR study

HealthBangladesh: Three people die due to dengue, fatalities in 2025 rise to 198

HealthIndian pharma exports expected to cross $30bn this year, rise sharply by 2030: Minister